Non-Thermal, Non-Ablative CO2 Laser Therapy (NACLT): A New Approach to Relieve Pain in Some Painful Oral Diseases by Nasrin Zand
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
16 
Non-Thermal, Non-Ablative CO2 Laser Therapy 
(NACLT): A New Approach to Relieve Pain in 
Some Painful Oral Diseases 
Nasrin Zand 
Iranian Center for Medical Lasers (ICML),  
Academic Center for Education, Culture and Research (ACECR), Tehran 
Iran 
1. Introduction 
CO2 laser has been used as a very useful device in surgery for ablation, coagulation and 
cutting the tissues for the last four decades. It is interesting to know that this high power 
laser can also be used as a therapeutic laser for immediate pain reduction in some oral lesions 
without any visible side effects such as ulceration, erosion formation and even erythema. 
Recently few case reports and clinical trials have been published about using CO2 laser in 
non-ablative manner to reduce pain in oral lesions. In these studies, the oral painful lesions 
were irradiated through a layer of transparent, non-anesthetic gel with high water content to 
reduce the beam absorption by the soft tissue. The patients reported immediate and 
significant pain relief after laser irradiation. The procedure was painless and anesthesia was 
not required. This technique was called non-thermal, Non-Ablative CO2 Laser Therapy 
(NACLT). The results of powermetry and thermometry demonstrated the low power nature 
of NACLT. However there are some differences between analgesic effects of NACLT and 
the other classical low power lasers which will be discussed in the next sections.   
To provide a comprehensive understanding of NACLT, this chapter is organized in several 
sections. First, due to low level therapeutic nature of NACLT, conventional low power 
therapeutic lasers, their biological effects and their pain relieving properties are reviewed. 
Then, a discussion about the interesting analgesic effects of CO2 lasers is presented. In the 
next section, NACLT as a new low level laser therapy procedure and its pain relieving 
applications in painful oral lesions is discussed. Finally, the presumed mechanisms of 
analgesic effects of NACLT are covered. 
2. Low level laser therapy (laser phototherapy)   
2.1 History 
Low-level laser (or light) therapy (LLLT) has been investigated and used clinically for over 
40 years. However, it is only in relatively recent times that LLLT has become scientifically 
and clinically accepted by even a fraction of the medical community (Hamblin 2010).  
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The history of the use of laser phototherapy in medicine goes back to the late 1960s, only 
eight years after the invention of the first laser (Ruby laser) by Theodore Maiman. In 1967, 
Endre Mester in Semmelweis University, Budapest, Hungary decided to test if laser 
radiation might cause cancer in mice. He shaved the dorsal hair of the mice, divided them 
into two groups and irradiated the shaved areas with a low powered ruby laser (694-nm) in 
one group. They did not get cancer and to his surprise the hair on the treated group grew 
back more quickly than the untreated group. This was the first demonstration of "laser 
biostimulation" (Hamblin, Waynant et al. 2006).  
In early 1960’s, the first low level laser, Helium-Neon was developed by Professor Ali Javan. 
It emits visible, red light with a wavelength of 632.8nm. This low power laser has been used 
extensively in experimental and therapeutic studies. Today, the semiconductor lasers, 
including InGaAlP lasers (633-700nm), GaAlAs lasers (780-890nm, invisible, near infrared 
area), GaAs laser (904nm, invisible, near infrared area) are widely used by researchers and 
clinicians.  
LLLT originally thought to be a peculiar property of laser light (soft or cold lasers); the 
subject has now broadened, using non-coherent light (light-emitting diodes, LEDs). Today, 
medical treatment with coherent-light sources (lasers) or noncoherent light (LEDs) has 
passed through its childhood and adolescence (Hamblin, Waynant et al. 2006). Currently, 
low-level laser (or light) therapy (LLLT) is practiced as part of physical therapy in many 
parts of the world. Although LLLT was used mainly for wound healing and pain relief, 
the medical applications of LLLT have broadened to include diseases such as stroke, 
myocardial infarction, and degenerative or traumatic brain disorders (Hashmi, Huang et 
al. 2010). 
Although many experimental and clinical studies have reported the positive effects of 
phototherapy to promote wound healing , pain relief and anti-inflammatory effects, some 
negative reports also have been published, further confounding the issue (Demidova-Rice, 
Salomatina et al. 2007), for instance regarding the application of laser phototherapy on 
wound healing (Posten, Wrone et al. 2005). This controversy seems to be due to two main 
reasons; first of all, the basic biochemical mechanisms underlying these biological effects are 
not completely understood. Secondly, the complexity of rationally choosing amongst a large 
number of laser irradiation parameters (such as wavelength, fluence, power density, pulse 
structure and treatment timing), inappropriate anatomical treatment location and 
concurrent patient medication (such as steroidal and non-steroidal anti-inflammatories 
which can inhibit healing) has led to conflicting results and publication of a number of 
unfavourable, as well as many favourable, studies.  In particular a biphasic dose response 
has been frequently observed where low levels of light have a much better effect than higher 
levels (Gigo-Benato, Geuna et al. 2005; Aimbire, Albertini et al. 2006; Hamblin, Waynant et 
al. 2006; Goncalves, Souza et al. 2007; Huang, Chen et al. 2009; Hamblin 2010). 
It should be noticed that LLLT has a diversified terminology. It is also called “cold laser”, 
“soft laser”, “biostimulation” ,  “photobiomodulation”, “low intensity laser therapy” , “low 
energy laser therapy”, “laser phototherapy (LPT)”, “laser therapy”, and “non-ablative 
irradiation”. Some investigators state that using frequent terms, such as “low power laser 
therapy” is misleading, since high power lasers, too, can be used for laser phototherapy  
(Tuner and Hode 2010) (as we will discuss in the next sections, CO2 laser is applied as a low 
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level (therapeutic laser) in NACLT, too). Some of the researchers favour the term “laser 
phototherapy (LPT)” which is an emerging terminology (Tuner and Hode 2010).  
2.2 A brief review on biological effects of low level therapeutic lasers 
Low level laser (or light) therapy (LLLT) is the application of light (usually a low power 
laser or LED in the range of 1mW – 500mW) to a pathology to promote wound healing and 
tissue repair, reduce inflammation and relieve pain. The light is typically of narrow spectral 
width in the red or near infrared spectrum (600nm – 1000nm); at power densities (between 
1mw-5W/cm2) (Huang, Chen et al. 2009), not associated with macroscopic thermal effects, 
in contrast to thermally mediated surgical applications (Chow, David et al. 2007). In using 
high power surgical lasers, the collimation of laser light leads to the emission of a narrow, 
intense beam of light and is used for precise tissue destruction (photothermal effect). 
However, in LLLT, light radiation intensities are so low that the resulting biological effects 
are ascribable to physical or chemical changes associated with the interaction of cells and 
tissues with the laser radiation, and not simply to a result of heating (Snyder, Byrnes et al. 
2002; Gigo-Benato, Geuna et al. 2005).  
The main areas of medicine where laser phototherapy has a known and major role are as 
follows: promoting wound healing, tissue repair and prevention of tissue death, relief of 
inflammation in chronic diseases and injuries with its associated pain and edema, relief of 
neurogenic pain and some neurological problems (Hamblin, Waynant et al. 2006). 
The first law of photobiology states that for low power visible light to have any effect on a 
living biological system, the photons must be absorbed by electronic absorption bands 
belonging to some molecular photoacceptors, or chromophores (Sutherland 2002; Huang, 
Chen et al. 2009). Red and near infrared light is absorbed by photoreceptors contained in the 
protein components of the respiratory chain located in  mitochondria, in particular 
cytochrome c oxidase and flavoproteins like NADH-dehydrogenase. This can lead to a short 
time activation of respiratory chain and oxidation of NADH pool leading to changes in the 
redox state of both mitochondria and cytoplasm, leading to increased ATP production, and 
biological responses at the cellular level through cascades of biochemical reactions (Karu 
1989; Karu, Pyatibrat et al. 2004; Karu and Kolyakov 2005). These effects in turn lead to 
increased cell proliferation and migration, modulation in levels of cytokines, growth factors, 
inflammatory mediators, and increased tissue oxygenation. The results of these biochemical 
and cellular changes in animals and patients lead to  valuable biological effects such as 
promoting wound healing and tissue repair, relief of inflammation, pain reduction, and 
amelioration of damage after heart attacks, stroke, nerve injury and even retinal toxicity 
(Hamblin, Waynant et al. 2006).  
2.3 Pain relieving effects of low level therapeutic lasers 
Low-level laser therapy (LLLT) is increasingly recognized as an appropriate option for pain 
relief. In fact, it is for this indication that biostimulative lasers have been approved for 
marketing by the U.S. Food and Drug Administration through the premarket 
notification/510(k) (Gigo-Benato, Geuna et al. 2005). Many studies have demonstrated the 
efficacy of phototherapy in various pain syndromes (Tuner and Hode 2010). Responding to 
the increasing levels of evidence, the World Health Organization’s Committee of the Decay 
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of the Bone and Joint has also recently incorporated LLLT into guidelines for treatment of 
neck pain (Haldeman, Carroll et al. 2008; Chow, Armati et al. 2011).  
 
“Efficacy of LLLT in painful clinical conditions has been established by several recent systematic 
reviews and meta-analyses [level 1 evidence, according to the Australian Government, NHMRC 
(1999)] (Chow, David et al. 2007). This level of evidence relates to chronic neck pain(Chow and 
Barnsley 2005), tendinitis (Bjordal, Couppe et al. 2001), chronic joint disorders (Bjordal, Couppe 
et al. 2003), and chronic pain (Enwemeka, Parker et al. 2004) . Randomized controlled trials 
(RCTs) provide level II evidence for the efficacy of laser therapy in chronic low back pain 
(Umegaki, Tanaka et al. 1989; Soriano and Rios 1998; Basford, Sheffield et al. 1999) . In other 
reviews of laser therapy for painful conditions such as rheumatoid arthritis (Brosseau, Robinson et 
al. 2005) and musculoskeletal pain (Gam, Thorsen et al. 1993; De Bie, De. Vet et al. 1998), the 
evidence is equivocal. Such variability in outcomes may be due to the multiplicity of parameters 
used, including wavelengths, energy, and power densities, with differing frequencies of 
application(Chow and Barnsley 2005).” (Chow, David et al. 2007) 
2.4 Mechanisms of analgesic effects of low level laser therapy 
The basic biological mechanisms behind the analgesic effects of conventional LLLT are not 
completely understood. Some of the explanations for these pain relieving effects are as follows:  
• Reversible blockage of action potential generation of nociceptive signals in primary 
afferent neurons and  specific reversible inhibition and functional impairment of Aδ 
and C fibers, which transmit nociceptive stimuli (Wakabayashi, Hamba et al. 1993; 
Kasai, Kono et al. 1996; Orchardson, Peacock et al. 1997; Chow, Armati et al. 2011). 
• Increase in β-endorphin synthesis and release (Labajos 1988; Montesinos 1988; 
Hagiwara, Iwasaka et al. 2007). 
• Inhibiting cyclooxygenase, interrupting conversion of arachidonic acid in to 
prostaglandins, especially prostaglandin E2 (PGE2) (Shimizu, Yamaguchi et al. 1995; 
Mizutani, Musya et al. 2004). 
• Suppression of Substance P, a neuropeptide associated with nociception (Ohno 1997). 
• Suppression of bradykinin activity, a pro-inflammatory neuropeptide that irritates 
nociceptors and is a key element in clinical pain and the associated inflammation 
(Maeda 1989; Jimbo, Noda et al. 1998) 
• Increased production of serotonin, affecting negatively neurotransmission (Tuner and 
Hode 2010) 
• Increased synaptic activity of acetylcholine esterase (Simunovic 2000) 
• Involvement of nitric oxide in analgesic effects of therapeutic lasers (Mrowiec 1997) 
• Single oxygen production, which in small amounts, is very important in biochemical 
processes and may be important in biostimulation 
• Decreased inflammation and subsequently decreased inflammatory sensitization of 
small-diameter afferent nerve endings 
• Improvement of  local microcirculation, increased tissue oxygenation, shift of 
metabolism from anaerobic to aerobic pathways, decreased production of acidic 
metabolites which stimulate the pain receptors 
• Increased lymphatic flow and consequently reducing edema, which leads to decreased 
sensitization of pain receptors 
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• Systemic effect, some researchers propose that laser phototherapy has both a local effect 
in the area treated by laser light, and a systemic effect through the release of metabolites 
(Tuner and Hode 2010). 
3. Pain relieving effects of carbon dioxide lasers 
Laser phototherapy is a relatively new application of carbon dioxide lasers, in spite of the 
fact that papers on the subject were published as early as the mid-eighties (Tuner and Hode 
2010). CO2 laser biostimulative and pain relieving effects can be assessed in the following 
two main groups:  
• The lower post operative pain following CO2 laser surgery compared to conventional 
surgery, which is attributed to the simultaneous low level laser therapy 
(photobiomodulation) effects of high power CO2 laser irradiation (Tuner and Hode 2010).  
• Application of CO2 laser, as a phototherapeutic laser. “For using CO2 laser as a low 
power therapeutic laser, one needs to make the beam wide enough not to burn. Another 
option is to scan rapidly over the lesion with a narrow beam. Therefore the power 
density or average power is kept low enough to avoid burning and their incident 
energy and power density are set within the low intensity  biostimulative laser therapy 
range” (Tuner and Hode 2010). NACLT is a new technique, in which CO2 laser is used 
in non-thermal, non-ablative manner as a biomodulative, low intensity laser for 
immediate and significant pain relief. (Zand, Ataie-Fashtami et al. 2009; Zand, 
Mansouri et al. 2009; Zand, Najafi et al. 2010). 
This section is organized as follows. At first some clinical studies which demonstrate the 
pain relieving effects of high power surgical CO2 lasers are reviewed, and then low power 
biostimulative CO2 laser studies are briefly reviewed. In the next section, NACLT as a new 
low power, biomodulative laser therapy protocol for pain reduction is introduced. 
3.1 Pain relieving effects of carbon dioxide laser as a high power surgical laser 
Some investigators who used the classical thermal effects of CO2 laser (vaporization, cutting 
and coagulation) reported less post-operative pain following CO2 laser surgery, and a reduced 
requirement for post-operative analgesics (Duncavage and Ossoff 1986; Colvard and Kuo 1991; 
Demidov, Rykov et al. 1992; Chia, Darzi et al. 1995; Kaplan, Kott et al. 1996; Andre 2003).  
Kaplan, one of the pioneers of CO2 laser surgery, attributed the excellent healing and lower 
post operative pain experienced with CO2 laser surgery compared to conventional surgery 
to the simultaneous laser therapy effects of CO2 laser irradiation. Kaplan stated that laser 
surgery and laser therapy should be regarded as two sides of the same coin (Kaplan, Kott et al. 
1996; Tuner and Hode 2010).  
Duncavage reported that the advantages of the CO2 laser  surgery included homeostasis, 
precise visualization, and less edema and pain than the conventional techniques 
(Duncavage and Ossoff 1986). 
Colvard and Kuo used high-power, ablative CO2 laser at a power output of 4 W under local 
anesthesia for painful minor aphthous ulcers of 14 patients.  In all, 88.8% of the patients in 
the study were completely pain free following anesthetic resolution, and none of the 
patients required post-operative medication for pain relief. (Colvard and Kuo 1991). 
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Demidov and his colleagues used high-energy CO2 laser as a laser scalpel in 120 cases of 
breast surgery including 70 operations for cancer. They reported reduced pain sensitivity in 
the region of the wounds in the postoperative period (Demidov, Rykov et al. 1992).  
In another study Chia reported that high-power CO2 laser haemorrhoidectomy was 
associated with a reduced requirement for post-operative analgesia (Chia, Darzi et al. 1995). 
Andre used classical high power CO2 laser at 10–15 W in continuous mode under local 
anesthesia for treating ingrowing nails of 302 patients. He reported that ingrowing nails 
were easily operated with the CO2 laser; bleeding was minimal, infection was rare, the 
wounds healed without exhudative drainage and cosmetic results were good. In addition 
the immediate post-operative pain was less severe than after classical nail surgery with 
scalpel (Andre 2003). 
In another study, Tada et al. compared the clinical effects and postoperative course of the 
scanning CO2 laser surgery and conventional surgical method to evaluate the clinical 
effectiveness of the former for the treatment of ingrowing nail deformities. They 
demonstrated that statistically, the operating time and the duration of postoperative pain 
were reduced significantly by the scanning CO2 laser. Furthermore, patients treated with 
CO2 laser were able to return to daily life significantly sooner (Tada, Hatoko et al. 2004). 
Kaviani et al. investigated whether the CO2 laser surgery was superior to conventional 
surgical techniques for minor breast surgery in a randomized clinical trial. They demonstrated 
that application of the CO2 laser in breast mass biopsy had some advantages, including a 
lower requirement for local anesthetic and a lower rate of intraoperative bleeding; however 
it did not reduce the postoperative pain grade severity (Kaviani, Fateh et al. 2008). 
Demetriades used ablative CO2 laser in painful oral aphthous ulcer of a patient with Behçet’s 
Syndrome. His experience showed transient pain relief following ablative CO2 laser 
irradiation (Demetriades, Hansford et al. 2009).  
3.2 Pain relieving effects of carbon dioxide laser as a low level (therapeutic) laser 
It is interesting to know that in addition to classical low level therapeutic lasers, surgical 
lasers could also be used as therapeutic instruments, for example; defocused CO2 laser 
10,600 nm, defocused ruby laser 694 nm and defocused Nd:YAG laser 1064 nm can be used 
for photobiomodulation. “When high power laser are used for biomodulation, one only 
needs to make the beam wide enough not to burn. The patient will then feel only a mild 
heat. An alternative is to scan rapidly over the lesion with a narrow beam. Therefore the 
power density or average power is kept low enough to avoid burning and their incident 
energy and power density are set within the low intensity laser therapy range” (Tuner and 
Hode 2010). 
The famous investigation of Mester with a low powered ruby laser (694-nm) on the shaved 
areas of the mice and quickly growing back of hairs can be an example of using a surgical 
laser as a therapeutic, biostimulative one (please see 2.1. History). 
At Uppsala Academic Hospital, a CO2-laser was tested successfully for biostimulative 
treatment of epicondylitis. This method was called EDL (Emitted Defocused Laser-light). It 
should be noted, however, that CO2-lasers were not used as surgical lasers in this study; 
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their incident energy and power density were set within the laser therapy range by 
spreading out the beam over such a large surface that the laser did not cause burning (Tuner 
and Hode 2010). 
Nicola used CO2 low power laser treating chronic pharyngitis. 85 patients with non-specific 
chronic pharyngitis were elected to be treated: Group Ι, 40 patients with predominance of 
hyperaemic aspect; and group II, 45 patients, predominance of hypertrophied aspect. Both 
groups were treated for 8 to 10 sessions. They concluded that this method was very suitable 
for the treatment of chronic pharyngitis (Nicola and Nicola 1994).   
In another study, 846 patients with different types of fibromyositic rheumatisms were 
submitted to defocalized laser therapy from 1980 to 1995.  They employed Diodes and CO2 
lasers. Control groups were used to compare results with those of traditional methods. 
Results were evaluated on the basis of subjective (such as local pain) and objective criteria. 
On the whole, results were positive in comparison with other methods both as regards 
recovery time and persistence of results. Approximately 2/3 of the patients benefited from 
the treatment indicated that there were greater advantages in use of laser over other 
presently available methods. Longo and  his collogues recommended that standardalization 
of treatment protocols deserves further studies (Longo, Simunovic et al. 1997). 
The CO2-laser can also be used as an acupuncture tool. Simulation of acupuncture points 
has been carried out both with biostimulating power densities (e.g.100mW/cm2) and 
burning/coagulation/ evaporation power densities. Some clinics state that CO2 lasers 
give better results on acupuncture points than HeNe lasers. “As the CO2 laser's beam 
cannot penetrate more than around 0.5 mm into tissue, the effects must be due to the 
influence of the laser energy on the cells encountered, so that signal substances are 
released and then circulate in the organism. This indirectly confirms the hypothesis that 
conventional laser therapy has both a local effect in the area treated by laser light, and a 
systemic effect through the release of metabolites. It is well known that these kinds of 
secondary effect also occur at the traditional wavelengths of 633, 830, and 904 nm” (Tuner 
and Hode 2010). 
4. NACLT (Non-Ablative CO2 Laser Therapy) 
Recently, there have been few reports about using CO2 laser in non-ablative manner to 
reduce pain in painful mucosal lesions (Elad, Or et al. 2003; Sharon-Buller and Sela 2004; 
Zand, Ataie-Fashtami et al. 2009; Zand, Mansouri et al. 2009; Zand, Najafi et al. 2010). 
In a report, Elad et al suggested that CO2 laser treatment could be of benefit to control pain 
in severe oral chronic graft-versus-host-disease (Elad, Or et al. 2003). In this study, the oral 
lesions of four patients were irradiated by CO2 laser during 17 sessions. The CO2 laser was 
applied, over mucosal lesions, using 1W power for 2-3s/1mm2. The treated mucosa was 
kept wet during the process. The treatment was pain free, and anesthesia was not required. 
The average VAS scores before, during, and immediately after CO2 laser treatment were 
8.09, 3.47, and 4.88 respectively. There was no visual damage to the oral mucosa and no 
aggravation of the oral lesions (Elad, Or et al. 2003).  
In another case report, aphthous ulcers of two patients were irradiated with CO2 laser at 1.0-
1.5 W power, with a defocused hand piece for 5 seconds. Before laser irradiation, a thin film 
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of Elmex Gel (a transparent gel with high water content) was placed on the lesions to reduce 
the beam absorption by the soft tissue. Anesthesia was not required since the treatment was 
not painful. The patients reported immediate pain relief after laser irradiation (Sharon-
Buller and Sela 2004).  
In these two reports, water (Elad, Or et al. 2003) and transparent gel with high water content 
(Sharon-Buller and Sela 2004) were used to reduce the beam absorption by the soft tissue. 
These interesting results encouraged us to conduct a randomized controlled clinical trial to 
confirm the pain-relieving effect of CO2 laser in minor aphthous ulcers as a prototype of 
painful oral lesions (Zand, Ataie-Fashtami et al. 2009). The results of this clinical trial 
demonstrated that a single session of low-intensity, non-thermal, CO2  laser irradiation could 
reduce pain in minor aphthous ulcers immediately and significantly, with no visible side 
effects (Zand, Ataie-Fashtami et al. 2009), the technique was called NACLT (Non-Ablative 
CO2 Laser Therapy) afterwards.   
In order to use the CO2 laser as a phototherapeutic laser for NACLT, the CO2 laser beam is 
irradiated through a thick layer of transparent gel with high water content to reduce the 
beam absorption by the tissue. In addition, the CO2 laser is operated with a de-focused hand 
piece 5–6 mm distant from the mucosal surface, scanning rapidly over the lesion with 
circular motion (Zand, Ataie-Fashtami et al. 2009; Zand, Mansouri et al. 2009; Zand, Najafi et 
al. 2010). The results of the powermetry have shown that the final laser power output, after 
passing through the gel, is reduced to 2-5 mW, which is in the range of low power lasers. 
Thermometry has also shown no significant temperature rise on the surface of the ulcers 
and under the gel layer during the laser irradiation, supporting the low power nature of the 
applied CO2 laser in NACLT(Zand, Ataie-Fashtami et al. 2009). It appears that due to high 
water content of the gel, it absorbs CO2 laser irradiation considerably, resulting in significant 
drops in the power output, by a factor of 200-500. In fact by irradiation of CO2 laser 
through a transparent gel with high water content, CO2 laser can be used as a non-
destructive, non-thermal laser to reduce pain in some oral lesions immediately and 
significantly. This technique was called non-ablative CO2 laser therapy (NACLT), in order 
to avoid any confusion with classical high power thermal CO2 laser effects. This technique 
could also be called non-thermal CO2 laser therapy (NTCLT) to avoid misinterpretation 
with fractional non-ablative lasers used for skin rejuvenation (Zand, Ataie-Fashtami et al. 
2009).  
NACLT is a pain free procedure and neither systemic nor topical anesthesia is required. The 
patients don’t feel warmth in their lesions during the procedure, in contrast to conventional 
defocused CO2 laser therapy in which the patients feel mild warmth.  Up to now, in the 
series of studies about the analgesic effects of NACLT, we have observed no visual effects of 
thermal damage to the oral mucosa such as tissue ablation, ulceration, erythema or 
aggravation of the lesions following the careful application of the technique (Zand, Ataie-
Fashtami et al. 2009; Zand, Mansouri et al. 2009; Zand, Najafi et al. 2010). So that the before-
after NACLT pictures of the lesions cannot be differentiated from each other easily (Figure 
1). Since there is no tissue ablation and plume formation during NACLT, in contrast to the 
classical ablative CO2 laser surgery, it seems rational to conclude that this procedure has no 
potential for carrying viral particles to the surgeon and other operating room staff (Zand, 
Ataie-Fashtami et al. 2009).  
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There are some differences between analgesic effects of NACLT and the other classical low 
power lasers. The analgesic effect in LLLT is usually gradual, cumulative, and multi-session 
(Pinheiro, Cavalcanti et al. 1998; Gur, Karakoc et al. 2002; Gur, Sarac et al. 2004; Nes and 
Posso 2005; Chow, Heller et al. 2006; Djavid, Mehrdad et al. 2007; Bjordal, Bensadoun et al. 
2011; Iwatsuki, Yoshimine et al. 2011; Ribeiro, de Aguiar et al. 2011). In contrast, the pain 
relieving effect of NACLT is immediate, dramatic and more sustained than conventional 
phototherapeutic lasers, so that immediately after NACLT, the patients of the studies have 
been able to eat and drink easily (Zand, Ataie-Fashtami et al. 2009; Zand, Mansouri et al. 
2009; Zand, Najafi et al. 2010).  
     
Fig. 1. Minor aphthous ulcers before and immediately after NACLT 
4.1 NACLT protocol 
At first, all standard precautions of laser utilization should be considered. Before laser 
irradiation, the patient and surgical staff should be given appropriate protective eye shields 
and eye glasses matched to the laser wavelength (10,600 nm) to protect inadvertent laser 
impact.1 Before laser irradiation, a layer of a transparent, non-anesthetic gel with high water 
content is placed on the lesion. In our studies, we use a transparent gel (Abzar Darman Co., 
Iran) with 87.5% water content, with a thickness of 3–4 mm on the lesion, is used. The CO2 
laser is operated at 1W power, with a de-focused hand piece, 5–6 mm distant from the 
mucosal surface, in continuous mode, scanning rapidly over the lesion with a circular 
motion. The irradiation time depends on the size of the lesion. For example, in our studies 
the irradiation time for minor aphthous ulcers is about 5-10 seconds. When using NACLT 
for larger lesions, such as; pemphigus vulgaris, every one centimeter square of the lesion has 
been irradiated for 5 seconds in each pass, and repeated immediately if the contact pain of 
the lesion persists. Between the passes, the prior gel should be wiped gently and replaced by 
a new layer of gel, otherwise the water content of the gel will decrease which may lead to 
increasing the beam absorption by the lesion and subsequent tissue injury and even 
burning. 
                                                 
1 In NACLT studies, we used eye glasses matched to the CO2 laser wavelength (10,600 nm), but we 
presume that it might be safer to use eye glasses matched to both the 10,600 nm and the guiding beam 
to protect the eyes from the reflected beam from the surface of the gel, the presumption that should be 
evaluated in further studies.  
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4.2 NACLT applications in clinical studies 
4.2.1 Recurrent oral aphthous stomatitis  
4.2.1.1 Definition 
Recurrent aphthous stomatitis (RAS) is a common oral disorder of uncertain 
etiopathogenesis (Scully, Gorsky et al. 2003), characterized by painful, round or ovoid ulcers 
with circumscribed margins, yellowish fibrinoid base, surrounded with erythematous 
haloes. The lesions typically first presenting in childhood or adolescence, recur at varying 
intervals throughout life (Jurge, Kuffer et al. 2006). The frequency and severity of the 
ulcerations usually decreases with age (Arikan, Birol et al. 2006). RAS occurs worldwide 
although it appears most common in the developed world (Jurge, Kuffer et al. 2006). 
Recurrent aphthous stomatitis (RAS) is classified into three clinical forms, namely minor 
(miRAS), major (maRAS) and herpetiformis. Minor aphthous ulcers, which comprise over 
80–90% of cases (Shashy and Ridley 2000), are less than 1 cm in diameter, last up to 7–14 
days, and they heal without scar formation. Major aphthous ulcers are over 1 cm in 
diameter, and their healing may take 20 to 30 days at a time and often heal with scarring. 
Herpetiform ulcers (HUs) are multiple, clustered, 1–3 mm lesions that may coalesce into 
larger ulcers. They typically heal within 15 days (Prolo P 2006).  
Although the exact underlying pathophysiology of RAS is not completely known, some 
evidences propose that aphthous ulcers are related to a focal immune dysfunction in which 
T lymphocytes have a significant role (Shashy and Ridley 2000; Jurge, Kuffer et al. 2006). 
Many etiologic, predisposing, and precipitating factors, such as genetic factors, 
immunologic problems, trauma,  hypersensitivity to foods and drugs, hormonal changes, 
hematological deficiencies, cessation of smoking, and psychological stresses have been 
propsed (Shashy and Ridley 2000; Arikan, Birol et al. 2006). 
Since there is no consensus regarding the cause of  recurrent oral aphthous ulcers, it is 
difficult to have completely effective treatment or prevention (Shashy and Ridley 2000). 
There are currently few agents that have been found in randomized controlled clinical trials 
to cure aphthous ulcers (Jurge, Kuffer et al. 2006). As a result, the management of RAS is 
directed largely toward symptomatic relief. The main problem with aphthous ulcers is their 
pain which may be so severe. Many different therapeutic agents, including topical 
corticosteroids, mouth rinses, antibiotics, local anesthetic gels or pastilles, and treatment 
modalities, such as silver nitrate cautery and cryotherapy, have been tried for pain control in 
miRAS patients (Alidaee, Taheri et al. 2005; Arikan, Birol et al. 2006). 
 
Fig. 2. Minor aphthous ulcer 
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Fig. 3. Major aphthous ulcer 
4.2.1.2 NACLT and minor oral aphthous stomatitis 
A randomized controlled clinical trial was designed to evaluate the pain relieving effects of 
a single-session of NACLT in minor recurrent aphthous stomatitis as a prototype of painful 
oral ulcers. Fifteen patients, each with two discrete aphthous ulcers, were included. One of 
the ulcers was randomly allocated to be treated with NACLT and the other one served as a 
placebo. In each patient, the laser lesion was treated with NACLT, while the placebo lesion 
was irradiated with the same laser, but with an inactive probe. The patients scored and 
recorded the pain severity of their lesions on a 10-grade visual analogue scale (VAS) up to 4 
days post operatively. In the laser group, the pain severity scores of the lesions were 
dramatically declined immediately after irradiation (p<0.001), whereas there were no 
changes in the mean scores in the placebo lesions at the same time. The reduction in pain 
scores was significantly greater in the laser group than in the placebo group in all of the 
follow up periods (p<0.001). The procedure itself was not painful, so anesthesia was not 
required. The patients reported no warmth in their lesions during laser treatment. There 
was no visual effect of thermal damage to the oral mucosa such as ablation, coagulation or 
erythema.  The results showed that a single-session of NACLT reduced pain in minor 
aphthous ulcers immediately and significantly, without any visible side effects (Zand, Ataie-
Fashtami et al. 2009). 
4.2.1.3 NACLT and major oral aphthous stomatitis 
A pilot randomized controlled clinical trial was designed to evaluate the analgesic effects of 
a single-session of NACLT in major recurrent aphthous ulcers.  Five patients, each with two 
discrete major aphthous ulcers were included. One of the ulcers was randomly allocated to 
be treated with NACLT and the other one served as a placebo. The lesions in laser group 
were irradiated with CO2 laser (λ = 10,600 nm; Lancet-2, Russia) through a thick layer of 
transparent, non-anesthetic gel (Abzar Darman Co., Iran) with 87.5% water content, with a 
thickness of 3–4 mm. The CO2 laser was operated at 1W power, with a de-focused hand 
piece, 5–6 mm distant from the mucosal surface, in continuous mode, scanning rapidly over 
the lesion with circular motion. The patients’ idiopathic (non-contact) and contact pain 
severity scores were recorded before and immediately after NACLT. These scores were also 
recorded up to 4 days post- operatively.  The results of the study demonstrated that in the 
laser group, both the non-contact  and contact pain  severity scores of the lesions were 
dramatically declined immediately after irradiation (p<0.001), whereas there were no 
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changes in the mean scores in the placebo lesions at the same time. The reduction in pain 
scores was significantly greater in the laser group than in the placebo group in all of the 
follow up periods (p<0.001). There were not any visible side effects following NACLT. None 
of the patients reported warmth feeling in their lesions during laser treatment. The results of 
the study suggested that a single-session of NACLT could reduce pain in major aphthous 
ulcers immediately and significantly, without any visible side effects (Zand, Ataie-Fashtami 
et al. 2009). This study is in progress.  
4.2.1.4 Literature review 
Colvard and Kuo evaluated the potential efficacy of the high-power, surgical CO2 laser for 
pain relief in 28 painful minor aphthous ulcers of 14 patients.  Their anesthetic protocol 
included pre-operative pain medication (oral administration of ketoprofen) and local 
anesthesia by infiltration of 1:200,000 2% isocaine with 1:200000 neocobefrin to overcome the 
painful nature of the procedure. During the procedure, CO2 laser was used as a classical, 
ablative manner with power output 4 W and as much necrotic tissue as possible was 
removed. Over all 88.8% of the patients were completely pain free following anesthetic 
resolution, and none of the patients required post-operative medication for pain relief. The 
authors concluded that CO2 laser should be included as an alternative modality for the 
treatment of miRAS, due to its ability to reduce or eliminate pain (Colvard and Kuo 1991). In 
this study, CO2 laser was used in classical, high power ablative manner. However the post 
operative analgesic effects of the procedure demonstrated the simultaneous biomodulative 
effects of CO2 laser irradiation. The same concept Kaplan stated that laser surgery and low 
level laser therapy should be regarded as two sides of the same coin. 
Fekrazad et al. evaluated the effects of Nd: YAG laser (power: 3 W, energy: 100 mj, pulse 
repetition rate: 30Hz, irradiation time: 60 sec) in 138 patients with aphtous ulcers. The 
patients were randomly assigned into three groups, as follows: (1) treatment with a 
focalized beam; (2) treatment with a non-focalised beam and (3) placebo treatment. In group 
(1) the laser beam was administered from a distance of 6 mm from the centre of the ulcer 
without using a clear and defined point of irradiation. In group (2) a well defined point 
beam of the laser was irradiated from a distance of 2 mm from the center of the ulcer, in a 
helical fashion. In group (3) the HeNe Laser was used as placebo with inactive probe. In 
group (1) and (2) a significant reduction of pain was observed compared to group (3).  The 
duration of pain and the duration of  recovery period were shortest in group (2) (Fekrazad, 
Jafari et al. 2006). 
De Souza TO et al. assessed the effect of low-level laser therapy on pain control and the 
repair of recurrent aphthous stomatitis. Twenty patients with recurrent aphthous ulcers 
were divided into two groups. The patients in Group I (n = 5) treated with topical 
triamcinolone acetonide and the patients in Group II (n = 15) received laser treatment 
with an InGaA1P diode laser (670 nm, 50 mW, 3 J/cm2 per point) in daily sessions on 
consecutive days. All patients were assessed daily, and the following clinical parameters 
were determined during each session: pain intensity before and after treatment and 
clinical measurement of lesion size. The results showed that 75% of the patients reported a 
reduction in pain in the same session after laser treatment, and total regression of the 
lesion occurred after 4 days. Total regression in the corticosteroid group was from 5 to 7 
days. They concluded that LLLT with these laser parameters demonstrated analgesic and 
healing effects with regard to recurrent aphthous stomatitis (De Souza, Martins et al. 2010). 
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Managing aphthous 
ulcers: 
Laser Treatment 
Applied 
Colvard M, 
Kuo P 
 
Before-after 
clinical trial 
1991 
Ablative CO2 laser 
surgery 
 
+ 18 
CO2-laser treatment of 
ulcerative lesions 
Sharon- 
Buller A, 
et al. 
Case report 
2004 
CO2  laser irradiation 
of the lesions  
through a thin film 
of transparent gel 
with high water 
content 
_ 2 
Relieving pain in 
minor aphthous 
stomatitis 
by a single session of 
non-thermal carbon 
dioxide laser 
irradiation 
Zand N, 
Ataie-
fashtami L. 
et al. 
 
Randomized 
controlled 
clinical trial 
(RCT) 
2008 
CO2  laser 
Irradiation of the 
lesions  through a 
thick (3-4mm) layer 
of transparent gel 
with high water 
content; (NACLT) 
_ 15 
Analgesic effects of 
single session of Non-
Ablative CO2 Laser 
Therapy (NACLT) in 
major aphthous ulcers: 
(a preliminary study) 
Zand N, 
Ataie-
fashtami L. 
et al. 
 
Randomized 
controlled 
clinical trial 
(RCT) 
2009 
CO2  laser 
Irradiation of the 
lesions  through a 
thick (3-4mm) layer 
of transparent gel 
with high water 
content; (NACLT) 
- 5 
Table 1. Irradiation of aphthous ulcers with CO2 laser 
4.2.2 Behçet’s disease 
4.2.2.1 Definition 
Behçet’s disease (BD) which is classified among vasculitides is a complex, multisystem 
inflammatory disease characterized by oral and genital aphthae, cutaneous lesions, arthritis, 
ocular, gastrointestinal, and neurologic manifestations (Meador, Ehrlich et al. 2002; Suzuki 
Kurokawa and Suzuki 2004; Lin and Liang 2006). 
The most common clinical feature is the presence of recurrent and usually painful 
mucocutaneous ulcers (Lin and Liang 2006). Oral aphthosis is the most frequent and 
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constant manifestation of Behçet’s disease (Davatchi, Shahram et al. 2005) and  usually the 
initial presenting symptom in most, if not all, patients (Lin and Liang 2006) . The distinct 
difference between the clinical features of aphthous ulcers of RAS and Behçet’s Syndrome 
remains unclear.  The aphthous ulcers of Behçet’s disease are typically painful punched-out 
ulcers with a white yellowish fibrinoid base, surrounded with erythematous halo. They 
range in size from a few millimeters to 2 cm. These ulcers typically heal spontaneously 
within 1 to 3 weeks,usually without scarring (Ghate and Jorizzo 1999; Lin and Liang 2006).  
Genital ulceration occurs in approximately 75% of the patients with Behçet’s disease (Lin 
and Liang 2006). The genital aphthous ulcers are morphologically similar to the oral ulcers, 
except that lesions are usually larger, more painful, heal more slowly, recur less frequently 
and can have scarring tendency (Davatchi, Shahram et al. 2005; Lin and Liang 2006).  In 
females they are often larger than 10 mm, and deeper than oral lesions. They are localized 
on the vulva, vagina, and rarely cervix. The giant aphthous lesion of the vulva is frequent, 
causing dysfunction and leaving sometimes indelible cicatrix. In males, genital aphthosis is 
often seen on the scrotum, but may be seen also on the shaft of penis or on the meatus. 
Sometimes they become giant lesions (Davatchi, Shahram et al. 2005) . Genital ulcerations of 
Behçet’s disease may be very painful, exert a negative impact on the patient's quality of life, 
and these lesions are often refractory to multiple treatments(Kasugai, Watanabe et al. 2010).   
Treatment of Behçet’s disease is based on the clinical symptoms and severity of systemic 
involvement, including topical therapies as well as colchicine, dapsone, thalidomide, and 
immunosuppressants,  interferon-alpha/beta, anti-tumor necrosis factor antibody, the latter 
specially in treatment for the cases with poor prognosis including eye, intestine, vessel and 
central nervous system involvement (Suzuki Kurokawa and Suzuki 2004).  
The mucosal lesions, especially genital lesions can often become refractory to multiple 
treatments and present challenges to physicians. Topical or intralesional corticosteroids, oral 
pentoxifylline, sucralfate, dapsone, colchicine, and systemic low-dose corticosteroids, used 
either alone or in combination, are safe and having varying evidence for effect in mild to 
moderate mucocutaneous disease. Azathioprine or methotrexate can be used if the lesions 
are refractory to the previously mentioned therapies. Tumor necrosis factor (TNF) inhibitors 
such as infliximab or etanercept should be considered as the next step treatments . 
Tacrolimus, cyclosporine, and interferon-alpha-2a should be used generally only if TNF 
inhibitors have failed as a result of their toxicities (Lin and Liang 2006).  
 
Fig. 4. Behçet’s Disease 
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4.2.2.2 NACLT and oral aphthous ulcers of Behçet’s disease 
A pilot before-after clinical trial was designed to evaluate the analgesic effects of a single-
session of NACLT in painful aphthous ulcers of Behçet’s disease. Up until the time of this 
publication,, three patients with known Behcet’s disease have been eligible and consented to 
participate in the study according the inclusion/exclusion criteria.  
Four painful oral aphthous ulcers of the three patients were treated by NACLT. The pain 
severity of the lesions were dramatically declined immediately after irradiation (p<0.001). 
This analgesic effect was consistently sustained during the five days follow-up periods. Up 
until the time of this publication, the results of this pilot study suggest that a single session 
of NACLT could relieve pain in oral aphthous ulcers of Behçet’s disease immediately and 
significantly without visible side effects of thermal damage or aggravation of the lesions.  
Similar to the other NACLT studies, the procedure itself was pain free and no anesthesia 
was required. The study is in progress. 
4.2.2.3 NACLT and genital aphthous ulcers of Behçet’s disease 
In another case report that is being published, the extremely painful genital aphthous ulcers 
of a 23-year-old female with Behcet’s disease were irradiated by NACLT. Before laser 
irradiation the pain of the lesions was so severe which impeded daily functions, such as 
sitting, walking, and even sleeping and did not respond to conventional analgesics. The 
non-contact and contact visual analogue scale (VAS) pain scores of the left genital ulcer were 
8 and 10 and the scores of the right sided ulcer were 6 and 10 respectively.  Immediately 
after NACLT of the ulcers and its surrounding erythematous rim, the contact pain of the 
lesions relieved completely (so that she could even walk downstairs without difficulties). 
Similar to the other prior NACLT investigations, there were no visual side effects of thermal 
damage to the lesions, such as tissue ablation or aggravation of the lesions following 
NACLT. The procedure was painless and neither systemic nor local anesthesia was 
required. This analgesic effect of NACLT was sustained during the healing period and she 
experienced no problem in daily functions and did not require topical or systemic 
analgesics. She just had mild burning sensation during urination for the first three days 
which relieved after healing of the lesions. It should be noted that concomitantly, 
treatment with prednisolone 30mg/day and colchicine  2mg/ day was initiated in the 
hospital. Additionally, the depth of the genital ulcers decreased remarkably two days after 
NACLT. The ulcers healed completely within 11 days which seemed to be much shorter 
than what was expected. Interestingly in spite of the large size of the ulcers, they left a 
very small (6mm) scar. The results of this case report suggest that NACLT could be 
potentially considered as an alternative method for pain relief in painful genital aphthous 
ulcers of Behçet’s disease without any complications.  
It should be noticed that Behçet’s syndrome is a serious multisystem disease, which in some 
cases it may lead to systemic complications such as; severe ocular problems (even 
blindness), intestinal, central nervous system,… involvement. Therefore the patients must be 
warned that NACLT should not substitute the systemic therapy of the disease in spite of its 
significant pain relieving effect. 
Certainly, controlled clinical trials with larger sample sizes are necessary to further evaluate 
the efficacy and safety of NACLT in reducing the pain of oral and genital aphthous ulcers of 
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Behcet’s disease. In addition such studies can demonstrate whether NACLT could accelerate 
wound healing in these lesions and specially prevent scar formation in genital aphthous 
ulcers of  Behcet’s disease or not.  
4.2.2.4 Literature review 
Demetriades used ablative CO2 laser in four painful oral aphthous ulcers of a patient with 
Behçet’s Syndrome. Before laser irradiation, the lesions were infiltrated with a minimal 
amount of lidocaine 2% with 1:100,000 epinephrine. A CO2-laser set at 2W superpulse 
mode with a 0.4 mm ceramic tip was used, in a defocused way to lightly char the surface 
of the ulcers. The patient tolerated the procedure well. On subsequent follow-up, one 
week after the procedure, the patient reported considerable relief of symptoms on most of 
the treated ulcers. The oropharyngeal ulcer displayed only moderate response, but the 
patient reported an overall improvement of his quality of life (Demetriades, Hansford et 
al. 2009). 
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A review of the literature 
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defocused 
CO2-laser 
irradiation 
+ 
Relieving pain in painful 
genital ulcers of Behcet’s 
disease by a single session 
of non thermal, Non-
Ablative CO2 Laser 
Therapy(NACLT): 
A Case Report 
Zand  N, Fateh M. 
Et al. 
Case report, 
under 
publish 
NACLT _ 
Immediate pain relief of 
oral aphthous ulcers of 
Behcet’s disease by non-
thermal, Non-Ablative CO2 
Laser Therapy (NACLT) 
Zand  N, Fateh M. 
Et al. 
Pilot before-
after clinical 
trial/ 
under 
publish 
NACLT - 
Table 2. Irradiation of aphthous ulcers of Behcet’s disease with CO2 laser 
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4.2.3 Pemphigus vulgaris 
4.2.3.1 Definition 
Pemphigus Vulgaris (PV) is a rare, potentially life-threatening, autoimmune blistering 
disease of the skin and mucous membranes. Although the disease can affect anyone, it is 
most prevalent in people of Mediterranean or Jewish ancestry(Bystryn and Rudolph 2005). 
The prevalence of the disease is 30/100,000 and annual incidence has been reported between 
1 and 5 in 100,000 according to different studies in Iran (Chams-Davatchi, Valikhani et al. 
2005; Asilian, Yoosefi et al. 2006). The lesions are characterized by intra-epidermal vesicles 
with acantholysis and an intact basal layer. In the majority of patients, painful mucous 
membrane erosions are the presenting sign of pemphigus vulgaris and may be the only sign 
for weeks to months before any bullous skin lesion develops. The mucous membranes most 
often affected are those of the oral cavity, in which intact blisters are rare, probably because 
they are fragile and break easily, leaving scattered and often extensive erosions. The lesions 
are usually multiple, superficial, and irregular in shape, and arise from mucosa of healthy 
appearance. Although any surface can be involved, the most common sites are the buccal 
and labial mucosa, the palate, and the tongue (Bystryn and Rudolph 2005). 
Oral lesions in pemphigus vulgaris may be so painful during the active period of the disease 
that may interfere with their eating, drinking and even speaking (Black, Mignogna et al. 
2005; Bystryn and Rudolph 2005).  
High doses of systemic corticosteroids plus immunosuppressive agents have dramatically 
declined the mortality rate of the disease. Understandably, owing to the life threatening 
nature of PV, the main focus of the peer reviewed literature has been on suppression and 
remission of PV (Rashid and Candido 2008). However, remission is not instantaneous and 
takes time to achieve. This delay in remission allows ample opportunity for complications to 
develop, secondary to the pain associated with PV. This can be highlighted by cases of 
repeated dehydration and malnutrition seen in PV patients (Rashid and Candido 2008). 
Therefore it seems necessary to obtain new modalities for pain control of these oral lesions 
during conventional systemic therapy. 
    
Fig. 5. Pemphigus vulgaris 
4.2.3.2 NACLT and oral lesions of pemphigus vulgaris 
A pilot before-after clinical trial was designed to evaluate the analgesic effects of application 
of a single session of NACLT in oral lesions of PV. Thirty eight painful oral lesions of ten 
patients with PV were irradiated with CO2 laser by NACLT protocol. The patients scored 
and recorded the pain severity of their lesions on a visual analogue scale (VAS) up to 7 days 
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post operatively. Immediately after NACLT, the severity of idiopathic (non-contact) and 
contact pain were dramatically declined (p<0.001), so that the patients could eat and drink 
without any difficulties.  This analgesic effect was sustained during follow-up periods. 
There was no visual effect of thermal damage to the oral mucosa or aggravation of the 
lesions. The results of this pilot study suggested that a single session of NACLT could 
reduce pain in oral lesions of pemphigus vulgaris immediately and significantly, without 
visible side effects (Zand, Mansouri et al. 2009). We recommend that in further studies, the 
pain severity of the lesions should be followed up for longer periods of time. 
It should be noted that due to the life threatening nature of PV without appropriate systemic 
treatment, the patients must be warned that NACLT should not alter their conventional treatment at 
all, in spite of its significant analgesic effect, as we instructed our patients to comply with their 
prescribed medical regimen. 
4.2.3.3 Literature review 
In a case report, the oral lesions of two patients with recalcitrant oral pemphigus vulgaris 
(who were under systemic treatment) were irradiated with CO2 laser at 1-1.5 W in a 
defocused mode for 5-10 seconds. The patients reported no pain after treatment. Recall 
examination after 1 month, 3 months and 5 month revealed complete healing of the lesions 
with no recurrence (Bhardwaj, Joshi et al. 2010). 
The pictures of the paper demonstrate the themal, ablative nature within the procedure. Its 
pain relieving effects can be explained by its simultaneous biomodulative effects of CO2 
laser irradiation. 
 
Title Author Study 
Type of 
irradiation 
N
ee
d
 t
o
 
A
n
es
th
es
ia
 
N
u
m
b
er
 o
f 
p
at
ie
n
ts
 
Relieving pain in 
painful oral lesions of 
pemphigus vulgaris 
by a single session, 
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nm CO2 Laser  
irradiation (pilot 
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Mansouri, 
P. et al. 
Before-after 
clinical trial 
2009 
NACLT _ 
Ten  
patients/38 
lesions 
Management of 
recalcitrant  oral 
pemphigus vulgaris 
with CO2 laser-
Report of two cases 
Bhardwaj, 
A. et al. 
Case report 
2010 
CO2 laser 
Irradiation of 
the lesions in a 
defocused 
mode 
(thermal) 
? 
Two 
patients/? 
lesions 
Table 3. Irradiation of oral lesions of pemphigus vulgaris with CO2 laser 
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4.2.4 Post chemotherapy oral mucositis 
4.2.4.1 Definition 
Oral mucositis is a common, debilitating, and potentially serious complication of 
chemoradiotherapy. Studies have shown that mucositis will develop in about 40% of 
chemotherapy patients, 80% of bone marrow transplant patients, and 100% of patients 
treated with radiotherapy to the head and neck (Berger & Kilroy 1997; Sonis et al. 1999). 
It presents as erythema, edema, ulceration, bleeding along with pain. The pain of the lesions 
is aggravated by the patient’s swallowing and normal oral functioning. Consequently, oral 
intake difficulties lead to loss of weight. The progression of oral lesions and their impact on 
the patient’s general condition may require nasogastric tube feeding or temporary 
discontinuation of the treatment or modification of the therapeutic plan (Arora, Pai et al. 2008).  
Pathologic evaluation of mucositis reveals mucosal thinning leading to a shallow ulcer 
thought to be caused by inflammation and depletion of the epithelial basal layer with 
subsequent denudation and bacterial infection. The wound healing response to this injury is 
characterized by inflammatory cell infiltration, interstitial exudate, fibrin and cell debris 
producing a “pseudomembrane” (Sonis 2004). 
Various preventive measures causing alteration of mucosa (cryotherapy, allopurinol, 
pilocarpine, leucovorin), modification of mucosal proliferation (beta-carotene, glutamine, 
cytokines), and antimicrobial or anti-inflammatory action (chlorhexidine, corticosteroids) 
have been tried. General oral care, diet, topical mucosal coating agents (sucralfate, 
magnesium hydroxide), topical anesthetics, and systemic analgesics ( opiods and non 
opioids) (Arora, Pai et al. 2008), recombinant human keratinocyte growth factor (palifermin) 
and Amifostine have also been suggested (Kuhn, Porto et al. 2009). However, currently no 
definitive preventive or therapeutic intervention exists that is completely successful at 
preventing oral mucositis and treatment for this complication has thus been symptomatic 
(Arora, Pai et al. 2008).  
 
Fig. 6. Post Docetaxole chemotherapy oral mucositis 
4.2.4.2 NACLT and mild to moderate post chemotherapy oral mucositis 
A pilot before-after clinical trial was designed to evaluate the effects of single session of non-
thermal, Non-ablative CO2 Laser therapy (NACLT) to reduce pain in mild to moderate oral 
mucositis following breast cancer chemotherapy with Docetaxole. Six patients were 
included and their oral lesions were irradiated by NACLT. The patients reported the 
idiopathic (non-contact) and contact pain of their lesions on VAS (visual analogue scale) 
before and immediately after laser and up to 7 days post operatively. The results of the 
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study showed that dramatically after NACLT, the severity of pain declined immediately 
and it was sustained during follow-up periods (P<0.001). Similar to the other NACLT 
clinical trials, the procedure itself was painless and anesthesia was not required. There was 
no visible side effect such as ulceration, erosion and even erythema following NACLT. The 
results of the study suggested that single session of NACLT could reduce pain in lesions of 
mild/moderate post Docetaxole oral mucositis immediately and dramatically without 
visible side effects (Zand, Najafi et al. 2010). 
4.2.4.3 A brief literature review 
Some studies have shown that laser phototherapy (LPT) can be useful in prevention or 
treatment of oral mucositis. The principle behind using laser phototherapy (LPT) is that it 
accelerates wound healing and has anti-inflammatory effects (Arora, Pai et al. 2008). In 
addition, pain relieving properties of low power lasers seem to be of value in management 
of painful lesions of oral mucositis (Arora, Pai et al. 2008).  
Some researchers state that prophylactic laser application seems more successful than 
curative laser application, although the reason is not entirely clear (Arora, Pai et al. 2008). 
Most studies of LLLT in cancer patients have focused on oral mucositis prevention 
(Bensadoun, Franquin et al. 1994; Bensadoun, Franquin et al. 1999; Rubenstein, Peterson et 
al. 2004; Bensadoun, Le Page et al. 2006; Kuhn, Porto et al. 2009; Clarkson, Worthington et al. 
2010; Bjordal, Bensadoun et al. 2011) . Since the subjects of this section refers to analgesic 
effects of low power lasers in established chemotherapy-induced oral mucositis (COM), we 
briefly review some articles in which LLLT has been used for relieving pain in patients with 
chemotherapy-induced oral mucositis and not the  prophylactic laser protocols.  
Cauwels and Martens evaluated the capacity of analgesic effect and wound healing of low 
level laser therapy in 16 children suffering from chemotherapy-induced oral mucositis. All 
children were treated using a GaAlAs diode laser (wavelength: 830 nm, potency: 150 mW). 
The energy released was adapted according to the severity of the oral lesions. The same 
protocol was repeated every 48 hours until healing of each lesion occurred. The results of 
the study demonstrated that immediately after irradiation of the oral mucositis, pain relief 
was noticed. Depending on the severity of oral mucositis, on average, 2.5 treatments per 
lesion in a period of 1 week were sufficient to heal a mucositis lesion. They concluded that 
LLLT could reduce the severity and duration of mucositis and to relieve pain significantly 
(Cauwels and Martens 2011). 
Nes and Posso investigated the pain relieving effect of LLLT among 13 patients who have 
developed moderate chemotherapy-induced oral mucositis. The laser used was GaAlAs (830 
nm, power: 250 mW, energy density: 35 J cm-2). The patients were treated during a 5-day 
period, and the pain was measured before and after each laser application. There was a 
significant ( P= 0.007) 67% decrease in the daily average experience of pain felt before and 
after each treatment, confirming that LLLT can relieve pain among patients who have 
developed chemotherapy-induced  oral mucositis (Nes and Posso 2005). 
4.2.5 Other NACLT studies 
We have evaluated the pain relieving effects of NACLT in some other painful mucosal 
lesions such as painful oral lesions of Stevens Johnson Syndrome, etc. as case reports, the 
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results of which are being published. In addition we have used NACLT in few ulcerated and 
non-ulcerated skin diseases with variable degrees of success. In some lesions, such as post 
herpetic neuralgia, NACLT acts like other conventional therapeutic lasers, in which the pain 
relieving effect is completely short standing and needs the several sessions of NACLT to be 
performed frequently. 
In addition, we have evaluated the effects of NACLT in promoting wound healing in few 
studies with variable degrees of success. Although in few studies, NACLT has shown some 
valuable results in this field we are not yet ready to express our view in this regard. 
Certainly, controlled clinical trials with larger sample sizes are necessary to further evaluate 
the promoting wound healing effects of NACLT.      
It should be mentioned that since the biological effects of NACLT and their mechanisms are not fully 
known, it seems ethically questionable to use NACLT in diseases with malignant potential, such as 
oral lichen planus, consequently we have not assessed the effects of NACLT in such illnesses.  
4.3 Presumed mechanisms of pain relieving effects of NACLT 
In order to develop an understanding of the mechanisms of analgesic effect of NACLT, 
powermetry and thermometry were performed in prior studies, the results of which 
demonstrated the low power nature of the applied CO2 laser (Zand, Ataie-Fashtami et al. 
2009).  (Please see also 4. NACLT)  
Since the analgesic effect of NACLT is immediate, we assume that at least in part, 
physiological neural changes such as blockage of action potential generation and conduction 
of nociceptive signals in primary afferent neurons might take part in this analgesic effect 
(Zand, Ataie-Fashtami et al. 2009). Destruction of nerve endings is less probable to be 
induced by NACLT, because, even in the studies in which CO2 laser has been used as a 
surgical scalpel, there have been no statistically significant differences in the number of 
intact peripheral nerve structures in  laser-treated sites in comparison with sites treated with 
electrocautery and scalpel (Rocha, Pinheiro et al. 2001). It is not known, whether  the other 
mechanisms such as increase in β-endorphin synthesis and release, changes in bradykinin, 
prostaglandins, substance P, serotonin, acetylcholine, nitric oxide, singlet oxygen 
production, and the other biochemical events- which have been proposed to play a part in 
pain relieving effect of conventional low power lasers - are responsible for analgesic effect of 
NACLT or not. (Please see also 2.4.Mechanisms of analgesic effects of low power laser 
therapy) Further basic studies are necessary to elucidate the mechanisms of this analgesic 
effect. 
On the other hand, there are some differences between analgesic effects of NACLT and the 
other classical low power lasers. The analgesic effect in LLLT is usually gradual, cumulative, 
and multi-session (Pinheiro, Cavalcanti et al. 1998; Gur, Karakoc et al. 2002; Gur, Sarac et al. 
2004; Nes and Posso 2005; Chow, Heller et al. 2006; Djavid, Mehrdad et al. 2007; Bjordal, 
Bensadoun et al. 2011; Iwatsuki, Yoshimine et al. 2011; Ribeiro, de Aguiar et al. 2011). In 
contrast, the pain relieving effect of NACLT is immediate, dramatic and more sustained 
than conventional low level therapeutic lasers (Zand, Ataie-Fashtami et al. 2009; Zand, 
Mansouri et al. 2009; Zand, Najafi et al. 2010). Therefore one could presume that the 
mechanisms of analgesic effect of NACLT might have some differences from that for 
conventional low power lasers, an assumption that should be assessed in further basic studies. 
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In some ulcerated oral lesions such as aphthous ulcers, the pain of the lesions derives from 
inflammatory sensitization of small-diameter afferent nerve endings that form a plexus at 
the junction of the epithelial and subepithelial layers. Branches of this plexus extend 
upward, into the epithelial layer; producing a superficial, focal, inflammatory lesion that 
is directly associated with exposed sensory nerve endings. Therefore, in such ulcers, CO2 
laser irradiation can reach the exposed nerve endings easily and as we assume, for 
example, block the action potential generation and conduction of nociceptive signals in 
primary afferent neurons. On the other hand, in other under-publish studies, we have 
used NACLT for reducing pain in few non-ulcerated lesions, such as pre-aphthous lesions 
with moderate-good results. As the CO2 laser's beam has a very limited depth of penetration 
in to the tissue, explaining this analgesic effect of NACLT seems more complex. 
Tuner and Hode state that the therapeutic effects of defocused CO2 laser must be due to the 
influence of the laser energy on the cells encountered, so that signal substances are released 
and then circulate in the organism. This indirectly confirms the hypothesis that conventional 
laser therapy has both a local effect in the area treated by laser light, and a systemic effect 
through the release of metabolites (Tuner and Hode 2010). We don’t know whether such 
mechanisms may at least in part, take part in the analgesic effect of NACLT or not. 
Further fundamental studies are necessary to elucidate the mechanisms of analgesic effect of 
NACLT. 
5. Conclusion 
CO2 laser has been used as a very useful high power, thermal laser in surgery for cutting, 
ablation and coagulation of the tissues for many years. In contrast, in non- thermal, Non-
Ablative CO2 Laser Therapy (NACLT), the CO2 laser is used as a low level 
(phototherapeutic) laser to reduce pain in some oral mucosal lesions without any visual 
effects of thermal damage to the oral mucosa such as ablation, ulceration or aggravation of 
the lesions. The results of powermetry and thermometry have demonstrated the low power 
nature of the applied CO2 laser in NACLT. 
As discussed above, in order to use the CO2 laser as a phototherapeutic laser for NACLT, 
the CO2 laser beam is irradiated through a thick layer of transparent, non-anesthetic gel with 
high water content. In addition, the CO2 laser is operated with a de-focused hand piece, 
scanning rapidly over the lesion with circular motion. With these considerations, CO2 laser 
can be used as a non-destructive, non-thermal, phototherapeutic laser (NACLT) to reduce 
pain in some oral mucosal lesions immediately and dramatically, so that after NACLT, the 
patients of the studies have been able  to eat and drink easily at once. So far, in the series of 
NACLT studies, we have not observed any visible side effects following careful 
performance of the technique.  
Certainly, controlled clinical trials with larger sample sizes will be able to prove the 
analgesic effects of NACLT more definitely. We recommend that in further studies, the pain 
severity of the lesions would be followed up for longer periods of time.  
In addition, it should be emphasized that in serious diseases such as pemphigus vulgaris, 
Behcet’s disease, etc., the patients must be warned that NACLT should not alter their 
conventional systemic treatment in spite of its significant analgesic effect. 
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fibers). The second part of the book is dedicated to applications in material processing (heat treatment,
welding, synthesis of new materials, micro fluidics) and in medicine (clinical applications, dentistry, non-ablative
therapy, acceleration of protons for cancer treatment).
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Nasrin Zand (2012). Non-Thermal, Non-Ablative CO2 Laser Therapy (NACLT): A New Approach to Relieve
Pain in Some Painful Oral Diseases, CO2 Laser - Optimisation and Application, Dr. Dan C. Dumitras (Ed.),
ISBN: 978-953-51-0351-6, InTech, Available from: http://www.intechopen.com/books/co2-laser-optimisation-
and-application/non-thermal-non-ablative-co2-laser-therapy-naclt-a-new-approach-to-relieve-pain-in-some-
painful-oral
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
